CNBC Tracks Midday Stock Movers Including Rogers, United Therapeutics, Moderna and FormFactor
CNBC's midday roundup flagged several stocks posting the largest price swings of the session, among them Rogers, United Therapeutics, Moderna and FormFactor.
Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.
CNBC's midday markets coverage highlighted a group of stocks registering the largest price moves of the trading session, including Rogers, United Therapeutics, Moderna and FormFactor, among others, according to the outlet's report.
The available source material does not include the specific percentage changes, trading volumes, or the underlying news or earnings catalysts behind each company's movement, so those details cannot be independently confirmed or reported here.
Midday stock roundups of this kind are a regular feature of financial news coverage, typically compiling a list of companies experiencing notable volatility due to factors such as earnings reports, analyst rating changes, regulatory news, merger and acquisition activity, or broader sector-wide trends.
United Therapeutics and Moderna are both biotechnology and pharmaceutical companies, sectors that often see outsized single-day moves tied to clinical trial results, regulatory decisions from bodies such as the US Food and Drug Administration, or shifts in broader healthcare policy.
FormFactor operates in the semiconductor testing equipment space, an industry sensitive to shifts in chip demand forecasts and technology sector sentiment, while Rogers Corporation is an industrial materials manufacturer whose shares can be affected by sector-specific demand signals or corporate developments.
Readers seeking the specific figures behind each company's midday move are advised to consult CNBC's full report directly, as the source excerpt available for this article did not provide the underlying data needed to detail individual price changes or their causes.
Sources
- Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Tanker Stocks, Not AI, Are the Market's Hottest Trade This Year, CNBC Reports
Shipping-focused tanker stocks have outperformed sharply in 2026, and CNBC reports analysts see reasons the rally could continue.
Applied Materials Shares Break Out Above Key Technical Level, CNBC Analysis Says
A CNBC options strategy analysis points to a bull put spread targeting further upside in Applied Materials toward the $615 level, while aiming to limit downside risk.
Micron Earnings Due After the Bell as Wall Street Awaits Results
Options traders see the earnings report as likely to be a 'slam dunk,' CNBC reported, as markets await Micron's results.
Citi Downgrades Moderna to Sell, Sees Shares Falling 60%
Analyst Geoff Meacham cut his rating on the biotech company after a rally that began in mid-August.
Kalshi Traders See High Odds of Anthropic IPO Announcement This Year
Betting odds rose after reports that Anthropic warned investors in an IPO prospectus that its AI models could be dangerous, CNBC reports.
HSBC upgrades Target to buy, citing further upside after strong year
Analyst Joe Thomas raised his rating on the retailer from hold to buy, according to CNBC.